Author:
Kaski J C,Girotti L A,Messuti H,Rutitzky B,Rosenbaum M B
Abstract
Twenty-three patients with sustained, recurrent, symptomatic ventricular tachycardia were treated with oral amiodarone. Initial doses were 600-2000 mg/day and maintenance doses were 200-1200 mg/day. Amiodarone was highly effective in 20 patients (87%), seven of whom had a follow-up of 30 months or longer, including two who were followed for 5 years. Three patients died within the first 45 days, three died suddenly after a follow-up of 33.5 months, and four had a nonarrhythmic death after a follow-up of 25 months. Fifteen patients (65%) had no recurrence during a follow-up of 21.5 months, while five (22%) had isolated recurrences during a follow-up of 32.2 months. The average maintenance dose was 713 mg/day in the 15 patients who did not have recurrences and 375 mg/day in the five patients who had recurrences (p less than 0.001). Both short- and long-term tolerance were excellent and there was not a single case in which treatment had to be discontinued. The main disadvantage of amiodarone was that it took an average of 9.5 days to reach anti-arrhythmic efficacy. The main advantages were prolonged duration of action (recurrences occurred only 15-60 days after the drug was discontinued or the dose lowered, virtual absence of contraindications, doses as high as 2000 mg/day were safe and patient compliance was excellent.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference23 articles.
1. Recherches dans la serie des benzofurannes. VII. Etude pharmacologique preliminaire due butyl- 2 (diiodo-3',5'-N-diethilaminoe&hoxy-4' benzoyl)-3 benzofuranne;Charlier R;Arch Int Pharmacodyn,1962
2. Recherches dans la serie des benzofurannes. XXXII. Mode d'action de l'amiodarone sur le systeme cardiovasculaire;Charlier R;Arch Int Physiol Biochim,1967
3. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart
4. Quality of the ideal antiarrhythmic drug
5. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride
Cited by
192 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献